Showing results (1381-1390 of 3,871) with videos related to
Sort By:
Pageof 388
Cancer Biology & Therapy|April 27, 2004
Spectroscopic sensing of cancer and cancer therapy: current status of translational researchIrving J Bigio, Stephen G BownCancer Biology & Therapy|April 27, 2004
Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblotMichiel S Van Der Heijden, Jonathan R Brody, Scott E KernCancer Biology & Therapy|October 14, 2005
Heterogeneity in non-invasive detection of apoptosis among human tumor cell lines using annexin-V tagged with EGFP or Qdot-705David T Dicker, Seok-Hyun Kim, Zhaoyu Jin, et al.Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.Cancer Biology & Therapy|December 17, 2005
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L Dahut, Nehal J Lakhani, James L Gulley, et al.Cancer Biology & Therapy|December 17, 2005
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imagingM E Eichhorn, S Becker, S Strieth, et al.Cancer Biology & Therapy|December 17, 2005
pRb2/p130 and VEGF expression in endometrial carcinoma in relation to angiogenesis and histopathologic tumor gradeFrancesca Sanseverino, Rosa Santopietro, Michela Torricelli, et al.Cancer Biology & Therapy|December 17, 2005
Differential gene expression profiling in aggressive bladder transitional cell carcinoma compared to the adjacent microscopically normal urothelium by microdissection-SMART cDNA PCR-SSHH T Wang, F L Ma, X B Ma, et al.Cancer Biology & Therapy|December 17, 2005
Production and post-surgical modification of VEGF, tPA and PAI-1 in patients with gliomaAndrea Salmaggi, Danilo Croci, Paola Prina, et al.Cancer Biology & Therapy|February 18, 2010
GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cellsXianping Shi, Deping Wang, Ke Ding, et al.Pageof 388